Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/13612Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kolettis, T. M. | en |
| dc.contributor.author | Vilaeti, A. | en |
| dc.contributor.author | Dimos, K. | en |
| dc.contributor.author | Tsitou, N. | en |
| dc.contributor.author | Agathopoulos, S. | en |
| dc.date.accessioned | 2015-11-24T17:31:40Z | - |
| dc.date.available | 2015-11-24T17:31:40Z | - |
| dc.identifier.issn | 1389-5575 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/13612 | - |
| dc.rights | Default Licence | - |
| dc.subject | biomaterial scaffold | en |
| dc.subject | cardiac repair | en |
| dc.subject | heart failure | en |
| dc.subject | myocardial infarction | en |
| dc.subject | ventricular remodeling | en |
| dc.subject | acute myocardial-infarction | en |
| dc.subject | ischemic mitral regurgitation | en |
| dc.subject | assembling peptide nanofibers | en |
| dc.subject | bioengineered cardiac grafts | en |
| dc.subject | mesenchymal stem-cells | en |
| dc.subject | growth-factor delivery | en |
| dc.subject | heart-failure | en |
| dc.subject | posterolateral infarction | en |
| dc.subject | smectite clays | en |
| dc.subject | model | en |
| dc.title | Tissue Engineering for Post-Myocardial Infarction Ventricular Remodeling | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | <Go to ISI>://000288985900006 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Μηχανικών Επιστήμης Υλικών | el |
| heal.publicationDate | 2011 | - |
| heal.abstract | Myocardial tissue engineering involves the design of biomaterial scaffolds, aiming at regenerating necrotic myocardium after myocardial infarction. Biomaterials provide mechanical support to the infarct area and they can be used as vehicles for sustained and controlled local administration of cells and growth factors. Although promising results have been reported in experimental studies, many issues need to be addressed before human use. | en |
| heal.publisher | Bentham Science Publications Ltd. | en |
| heal.journalName | Mini-Reviews in Medicinal Chemistry | en |
| heal.journalType | peer reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
